drugset / Trial / NCT00425932
Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis
Phase 2
Completed
60 enrolled
Gaylis, Norman B., M.D.
Genentech, Inc. · collabOklahoma Medical Research Foundation · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to further investigate rituximab in the treatment of rheumatoid arthritis and to evaluate magnetic resonance imaging of the joints as a possible method to improve the evaluation of treatments.
Timeline
- Start
- 2007-02
- Primary completion
- 2011-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rituximab | Monoclonal antibody | 1000 mg | Intravenous |